関連レポート

　次世代がん診断：技術および世界市場

サイト内検索

お探しの資料等をキーワード検索できます。英語検索も有効です。

出版元：BCC Research 　 出版元について

発行年：2022年2月

定価 Single User License(1名様ライセンス)US$5,500 (米国ドル) /2 to 5 Users License(5名様)$6,600 /Site License $7,920 / Enterprise License $9,504

ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。

ご請求は円換算（お見積り日TTSレート）となります。

納品形態：PDF by Email

当調査レポートは英文157ページになります。

商品コード：BCC373

【レポート紹介】

血中循環腫瘍細胞(CTC)検査の世界市場規模は2021年で88億ドル、2026年には152億ドルへと拡大し、市場の平均年成長率は15.6%に達する見込みです。
がんの有病率が高まる中、血中循環腫瘍細胞(CTC)はがん診断や精密管理への応用が期待されています。また市場の成長促進要因として、NGSや免疫蛍光などの技術進歩、がんの新しい診断方法についての認識の高まりなどが挙げられます。

当レポートでは、血中循環腫瘍細胞(CTC)検査の市場/技術的背景、CTC検査技術、COVID-19による血中循環腫瘍細胞(CTC)検査市場への影響、各種セグメント別市場分析(がんタイプ別、技術別、用途別、国地域別)、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場/技術的背景

・がん
・血中循環腫瘍細胞(CTC)
・がん患者における転移の進展
・メソッド

◆CTC検査技術

・血中循環腫瘍細胞(CTC)の検出

◆COVID-19による血中循環腫瘍細胞(CTC)検査市場への影響

・COVID-19とがん検診
・COVID-19による企業収益への影響

◆市場ダイナミクス

・ドライバー
・障壁
・機会
・競合状況

◆血中循環腫瘍細胞(CTC)検査市場、がんタイプ別

・乳がん
・結腸直腸がん
・前立腺がん
※市場予測データ-2026年掲載

◆血中循環腫瘍細胞(CTC)検査市場、技術別

・CTC濃縮検出
・CTC直接検出
・CTC分析
※市場予測データ-2026年掲載

◆血中循環腫瘍細胞(CTC)検査市場、用途別

・臨床/リキッドバイオプシー
・研究
※市場予測データ-2026年掲載

◆血中循環腫瘍細胞(CTC)検査市場、国地域別

北米
・米国、カナダ
欧州
・ドイツ、フランス、英国、イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド、オーストラリア
・その他アジア太平洋
その他地域
※市場予測データ-2026年掲載
※地域別に全セグメント別のデータ掲載

◆主要企業プロフィール

・BIO-TECHNE CORP. (ADVANCED CELL DIAGNOSTICS INC.)
・BIOCEPT, INC.
・BIOFLUIDICA
・CREATV MICROTECH INC.
・FLUXION BIOSCIENCES, INC.
・GREINER BIO-ONE INTERNATIONAL GMBH
・IKONISYS, INC.
・IVDIAGNOSTICS, INC.
・MENARINI SILICON BIOSYSTEMS (FORMERLY VERIDEX LLC)
・MILTENYI BIOTEC
・PRECISION MEDICINE GROUP LLC
・QIAGEN N.V.
・RARECELLS, INC.
・SCREENCELL
・STEMCELL TECHNOLOGIES INC.

(全157頁)

【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

Study Background
Study Goals and Objectives
Reasons for Doing this Study
Scope of Report
What's New in this Update?
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Chapter 3 Market and Technology Background

Cancer

• Recent Advances in Technology
• Invasive Power

Circulating Tumor Cells

• Phenotypic Characteristics
• CTC Clusters
• CTC Detection
• Cancer Stem Cells (CSCs)
• Circulating Tumor Cells -- Potential Uses
• Proliferative Activity
• Epithelial Marker Genes on Circulating Tumor Cells
• Circulating Tumor Cells and Stem Cell-Like Phenotype
• CTCs and Primary Tumor Cells: A Comparison
• Metastasis
• Future Directions

Metastatic Development in Cancer Patients

• Circulating Tumor Cell Migration
• Circulating Tumor Cell Detection

Methods

• CellSearch Method
• Epic Sciences Method
• Maintrac
• ISET Test
• Challenges for Detection
• Clinical Application of Circulating Tumor DNA
• Circulating Tumor Cells as Predictor of Response to Therapy
• Measurement of CTCs -- Applications
• Conclusion

Chapter 4 CTC Diagnostic Technologies

Finding Circulating Tumor Cells

• Why CTCs?
• Current CTC Detection and Isolation Methods
• New Technologies for Detection
• Cancer Prognosis
• Nucleic Acid-Based Methods
• Clinical Testing
• Summary
• New Emerging Technologies

Chapter 5 Impact of COVID-19 on the CTC Diagnostics Market

Overview
COVID-19 and Cancer Screening
Impact of COVID-19 on Company Revenues

Chapter 6 Market Dynamics

Market Drivers

• Rising Incidence of Cancer Worldwide
• Advantages Offered, by Noninvasivene Approach, by Circulating Tumor Cells
• Advancements in NGS and Immunofluorescence Technologies
• Growing Awareness About the Novel Diagnostic Methods for Cancers

Market Restraints

• High Costs of CTC Diagnostics
• Rarity of CTCs in Blood Samples and Lack of Skilled Professionals for CTC Diagnostics

Market Opportunities

• Circulating Tumor Cells as a Therapeutic Target

Competitive Landscape

Chapter 7 Market Breakdown by Cancer Type

Global Market for CTC Diagnostics by Cancer Type

• Breast Cancer
• Colorectal Cancer
• Prostate Cancer

Chapter 8 Market Breakdown by Technology

Global Market for CTC Diagnostics by Technology

• CTC Enrichment and Detection
• CTC Direct Detection
• CTC Analysis

Chapter 9 Market Breakdown by Application

Global Market for CTC Diagnostics by Application

• Clinical/Liquid Biopsy
• Research

Chapter 10 Market Breakdown by Region

Global Market for CTC Diagnostics by Region

• North America
• Europe
• Asia-Pacific
• Rest of World

Chapter 11 Company Profiles

BIO-TECHNE CORP. (ADVANCED CELL DIAGNOSTICS INC.)
BIOCEPT, INC.
BIOFLUIDICA
CREATV MICROTECH INC.
FLUXION BIOSCIENCES, INC.
GREINER BIO-ONE INTERNATIONAL GMBH
IKONISYS, INC.
IVDIAGNOSTICS, INC.
MENARINI SILICON BIOSYSTEMS (FORMERLY VERIDEX LLC)
MILTENYI BIOTEC
PRECISION MEDICINE GROUP LLC
QIAGEN N.V.
RARECELLS, INC.
SCREENCELL
STEMCELL TECHNOLOGIES INC.

Chapter 12 Appendix: List of Acronyms

List of Tables

Table A : New Additions to the Updated Version of the Report
Summary Table : Global Market for Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, Through 2026
Table 1 : Categories of Stem Cells
Table 2 : Product Categories
Table 3 : Key Characteristics of CTCs
Table 4 : Types of CTCs
Table 5 : Circulating Tumor Cells Features
Table 6 : Metastatic Cascade
Table 7 : EPCAM-Based Assays
Table 8 : Comparison of Different Liquid Biopsy Technologies
Table 9 : Potential Applications of CTC-Based Diagnostics
Table 10 : Clinical Relevance of CTC
Table 11 : CTC Enrichment Methods
Table 12 : Techniques Used for CTC Enrichment
Table 13 : Techniques Used for CTC Analysis
Table 14 : Enumeration Techniques
Table 15 : Functional Assays
Table 16 : Circulating Tumor Cells Technologies
Table 17 : Micro-Count Features: A New Technology
Table 18 : Ranking of Global Vendors of CTC Diagnostics, 2020
Table 19 : Global Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 20 : Global Market for CTC Diagnostics for Breast Cancer, by Region, Through 2026
Table 21 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, Through 2026
Table 22 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, Through 2026
Table 23 : Global Market for CTC Diagnostics, by Technology, Through 2026
Table 24 : CTC Enrichment Methods
Table 25 : Global Market for CTC Enrichment and Detection, by Region, Through 2026
Table 26 : Global Market for CTC Direct Detection, by Region, Through 2026
Table 27 : Global Market for CTC Analysis, by Region, Through 2026
Table 28 : Global Market for CTC Diagnostics, by Application, Through 2026
Table 29 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, Through 2026
Table 30 : Global Market for CTC Diagnostics in Research Applications, by Region, Through 2026
Table 31 : Global Market for CTC Diagnostics, by Region, Through 2026
Table 32 : North American Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 33 : North American Market for CTC Diagnostics, by Country, Through 2026
Table 34 : Estimated Number of New Cases and Age-Standardized Incidence Rates for Cancers in Canada, by Sex, 2020
Table 35 : European Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 36 : European Market for CTC Diagnostics, by Country, Through 2026
Table 37 : Asia-Pacific Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 38 : Asia-Pacific Market for CTC Diagnostics, by Country, Through 2026
Table 39 : Age-Standardized Cancer Incidence and Mortality Rates in China, by Gender, 2018
Table 40 : Rest of World Market for CTC Diagnostics, by Cancer Type, Through 2026
Table 41 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): R&D Expenditures, 2018-2020
Table 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Products Offered
Table 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Recent Developments
Table 44 : Biocept, Inc.: R&D Expenditures, 2019 and 2020
Table 45 : Biocept, Inc.: Solutions/Services Offered
Table 46 : Biocept, Inc.: Recent Developments
Table 47 : BioFluidica: Solutions/Services Offered
Table 48 : BioFluidica: Recent Developments
Table 49 : Creatv MicroTech Inc.: Products Offered
Table 50 : Creatv MicroTech Inc: Recent Developments
Table 51 : Fluxion Biosciences, Inc.: Solutions/Services Offered
Table 52 : Fluxion Biosciences, Inc.: Recent Developments
Table 53 : Greiner Bio-One International GmbH: Products Offered
Table 54 : Ikonisys, Inc.: Products Offered
Table 55 : Ikonisys, Inc.: Recent Developments
Table 56 : IVDiagnostics, Inc.: Products/Services Offered
Table 57 : IVDiagnostics, Inc.: Recent Developments
Table 58 : Menarini Silicon Biosystems: Products Offered
Table 59 : Menarini Silicon Biosystems: Recent Developments
Table 60 : Miltenyi Biotec: Products Offered
Table 61 : Precision Medicine Group LLC: Products Offered
Table 62 : Precision Medicine Group LLC: Recent Developments
Table 63 : Qiagen: Products Offered
Table 64 : Qiagen: Recent Developments
Table 65 : Rarecells, Inc.: Products Offered
Table 66 : Rarecells, Inc.: Recent Developments
Table 67 : ScreenCell: Products Offered
Table 68 : ScreenCell: Recent Developments, 2021
Table 69 : STEMCELL Technologies Inc.: Products/Services Offered
Table 70 : STEMCELL Technologies Inc.: Recent Developments
Table 71 : Commonly Used Acronyms in the Market for CTC Diagnostics

List of Figures

Summary Figure : Global Market Shares of Circulating Tumor Cells (CTC) Diagnostics, by Cancer Type, 2020
Figure 1 : Global Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 2 : Global Market for CTC Diagnostics for Breast Cancer, 2019-2026
Figure 3 : Global Market for CTC Diagnostics for Breast Cancer, by Region, 2019-2026
Figure 4 : Global Market for CTC Diagnostics for Colorectal Cancer, 2019-2026
Figure 5 : Global Market for CTC Diagnostics for Colorectal Cancer, by Region, 2019-2026
Figure 6 : Global Market for CTC Diagnostics for Prostate Cancer, 2019-2026
Figure 7 : Global Market for CTC Diagnostics for Prostate Cancer, by Region, 2019-2026
Figure 8 : Global Market Shares of CTC Diagnostics, by Technology, 2020
Figure 9 : Global Market for CTC Enrichment and Detection, 2019-2026
Figure 10 : Global Market for CTC Enrichment and Detection, by Region, 2019-2026
Figure 11 : Global Market for CTC Direct Detection, 2019-2026
Figure 12 : Global Market for CTC Direct Detection, by Region, 2019-2026
Figure 13 : Global Market for CTC Analysis, 2019-2026
Figure 14 : Global Market for CTC Analysis, by Region, 2019-2026
Figure 15 : Global Market Shares of CTC Diagnostics, by Application, 2020
Figure 16 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, 2019-2026
Figure 17 : Global Market for CTC Diagnostics in Clinical/Liquid Biopsy Applications, by Region, 2019-2026
Figure 18 : Global Market for CTC Diagnostics in Research Applications, 2019-2026
Figure 19 : Global Market for CTC Diagnostics in Research Applications, by Region, 2019-2026
Figure 20 : Global Market for CTC Diagnostics, by Region, 2019-2026
Figure 21 : Global Market Shares of CTC Diagnostics, by Region, 2020
Figure 22 : North American Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 23 : North American Market Shares of CTC Diagnostics, by Country, 2020
Figure 24 : U.S. Market for CTC Diagnostics, 2019-2026
Figure 25 : Canadian Market for CTC Diagnostics, 2019-2026
Figure 26 : European Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 27 : European Market Shares of CTC Diagnostics, by Country, 2020
Figure 28 : German Market for CTC Diagnostics, 2019-2026
Figure 29 : French Market for CTC Diagnostics, 2019-2026
Figure 30 : U.K. Market for CTC Diagnostics, 2019-2026
Figure 31 : Italian Market for CTC Diagnostics, 2019-2026
Figure 32 : Spanish Market for CTC Diagnostics, 2019-2026
Figure 33 : Rest of European Market for CTC Diagnostics, 2019-2026
Figure 34 : Asia-Pacific Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 35 : Asia-Pacific Market Shares of CTC Diagnostics, by Country, 2020
Figure 36 : Chinese Market for CTC Diagnostics, 2019-2026
Figure 37 : Indian Market for CTC Diagnostics, 2019-2026
Figure 38 : Japanese Market for CTC Diagnostics, 2019-2026
Figure 39 : Australian Market for CTC Diagnostics, 2019-2026
Figure 40 : Rest of Asia-Pacific Market for CTC Diagnostics, 2019-2026
Figure 41 : Rest of World Market Shares of CTC Diagnostics, by Cancer Type, 2020
Figure 42 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Net Revenue, 2016-2020
Figure 43 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Business Segment, 2020
Figure 44 : Bio-Techne Corp. (Advanced Cell Diagnostics Inc.): Revenue Share, by Region, 2020
Figure 45 : Biocept, Inc.: Net Revenue, 2016-2020
Figure 46 : Greiner Bio-One International GmbH: Net Revenue, 2016-2020
Figure 47 : Greiner Bio-One International GmbH: Revenue Share, by Business Segment, 2020
Figure 48 : Greiner Bio-One International GmbH: Revenue Share, by Region, 2020
Figure 49 : Qiagen: Net Revenue, 2016-2020
Figure 50 : Qiagen: Revenue Share, by Business Segment, 2020
Figure 51 : Qiagen: Revenue Share, by Region, 2020